Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CHLOROTHIAZIDE USP, with a corresponding US DMF Number 22730.
Remarkably, this DMF maintains an Active status since its submission on May 07, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 12, 2020, and payment made on June 09, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II